Study of fas-mediated Foxp3 + CD4 + CD25 + Treg cell apoptosis in patients with systemic lupus erythematosus

National Medical Journal of China

Volumn 91, Issue 9, 2011, Pages 586-590

  Lin, Xiao Jun ^a   Luo, Min ^a   Cai, Xiao Yan ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Apoptosis; Fas; Foxp3 + CD4 + CD25 + regulatory T cell; Lupus erythematosus, systemic

Indexed keywords

FAS LIGAND; TRANSCRIPTION FACTOR FOXP3;

APOPTOSIS; ARTICLE; BLOOD; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROL GROUP; DISEASE ACTIVITY; HUMAN; PROTEIN EXPRESSION; REMISSION; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; ADOLESCENT; ADULT; AGED; CASE CONTROL STUDY; CYTOLOGY; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; APOPTOSIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84869796295     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2011.09.003     Document Type: Article

References (13)

1. Mudd PA, Teague BN, Farris AD. Regulatory T cells and systemic lupus erythmatosis. Scand J Immunol, 2006, 64: 211-218.
2. Fehervari Z, Sakaguehi S. CD4 + Tregs and immune control. J Clin invest, 2004, 114: 1209-1217.
3. Fontenot JD, Rasmussen JP, Gavin MA, et al. A function for interleukin 2 in FoxP3-expressing regulatory T cells. Nat Immunol, 2005, 6: 1142-1151.
4. Lyssuk EY, Torgashina AV, Soloviev SK, et al. Reducced number and function of CD4 + CD25 + high FoxP3 regulatory T cells in patients with systemic lupus erythematous. Adv Exp Med Biol, 2007, 601: 113-119.
5. Vargas-Rojas MI, Crispin JC, Richaud-Patin Y, et al. Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus, 2008, 58: 801-812.
6. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40: 1725.
7. Bombardier C, Gladam DD, Urowitzm B, et al. Derivation of the SLEDAI a disease activity index for lupus patients, the committee on prognosis studies in SLE. Arthritis Rheum, 1992, 35: 630-640.
8. Cuda CM, Wan S, Sobe ES, et al. Murine lupus susceptibility locus Slela controls regulatory T cell number and function through multiple mechanisms. J Immunol, 2007, 179: 7349-7447.
9. Fritzsching B, Oberle N, Eberhardt N, et al. In contrast to effector T cells, CD4 + CD25 + Foxp3 + regulatory T cells are highly susceptible to CD95 ligand-but not to TCR-mediated cell death. J Immunol, 2005, 175: 32-36.
10. 2006, 22: 588-593.
11. 2006, 26: 800-804.
12. Kalaaji M, Fenton KA, Mortensen ES, et al. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int, 2007, 71: 664-672.
13. 2007, 87: 3102-3106.